HEADER TRANSFERASE/TRANSFERASE INHIBITOR 07-DEC-16 5U6B TITLE STRUCTURE OF THE AXL KINASE DOMAIN IN COMPLEX WITH A MACROCYCLIC TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE RECEPTOR UFO; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: UNP RESIDUES 514-818; COMPND 5 SYNONYM: AXL ONCOGENE; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AXL, UFO; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE INHIBITOR COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.S.GAJIWALA,N.GRODSKY REVDAT 4 06-MAR-24 5U6B 1 REMARK REVDAT 3 04-OCT-17 5U6B 1 JRNL REVDAT 2 02-AUG-17 5U6B 1 JRNL REVDAT 1 26-JUL-17 5U6B 0 JRNL AUTH K.S.GAJIWALA,N.GRODSKY,B.BOLANOS,J.FENG,R.FERRE, JRNL AUTH 2 S.TIMOFEEVSKI,M.XU,B.W.MURRAY,T.W.JOHNSON,A.STEWART JRNL TITL THE AXL KINASE DOMAIN IN COMPLEX WITH A MACROCYCLIC JRNL TITL 2 INHIBITOR OFFERS FIRST STRUCTURAL INSIGHTS INTO AN ACTIVE JRNL TITL 3 TAM RECEPTOR KINASE. JRNL REF J. BIOL. CHEM. V. 292 15705 2017 JRNL REFN ESSN 1083-351X JRNL PMID 28724631 JRNL DOI 10.1074/JBC.M116.771485 REMARK 2 REMARK 2 RESOLUTION. 2.84 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.84 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 31142 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.840 REMARK 3 FREE R VALUE TEST SET COUNT : 759 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 16 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.84 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.93 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.83 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2868 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2510 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2722 REMARK 3 BIN R VALUE (WORKING SET) : 0.2490 REMARK 3 BIN FREE R VALUE : 0.2880 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.09 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 146 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8918 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 128 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 74.19 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.15180 REMARK 3 B22 (A**2) : 11.94730 REMARK 3 B33 (A**2) : -10.79550 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.54260 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.400 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.351 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.903 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.880 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 9238 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 12478 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 3280 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 228 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 1420 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 9238 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 1154 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 10404 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.36 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 22.31 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5U6B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-DEC-16. REMARK 100 THE DEPOSITION ID IS D_1000225398. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-DEC-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31278 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.840 REMARK 200 RESOLUTION RANGE LOW (A) : 63.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09500 REMARK 200 FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.84 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.99 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.56500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.2 MICROL OF THE PROTEIN-LIGAND REMARK 280 COMPLEX (1:3 RATIO OF PROTEIN:LIGAND) AND 1.2 MICROL OF THE REMARK 280 RESERVOIR SOLUTION (0.1 M TRIS, PH 8.5, 0.2 M MGCL2, 30 % (W/V) REMARK 280 PEG-4000, 1-2 % (V/V) 1-BUTANOL)., VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 50.35200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 512 REMARK 465 SER A 513 REMARK 465 ASN A 514 REMARK 465 SER A 515 REMARK 465 LEU A 516 REMARK 465 GLY A 517 REMARK 465 ILE A 518 REMARK 465 SER A 519 REMARK 465 GLU A 520 REMARK 465 GLY A 607 REMARK 465 SER A 608 REMARK 465 GLU A 609 REMARK 465 ARG A 610 REMARK 465 GLU A 611 REMARK 465 SER A 612 REMARK 465 PHE A 613 REMARK 465 LYS A 696 REMARK 465 ILE A 697 REMARK 465 TYR A 698 REMARK 465 ASN A 699 REMARK 465 GLY A 700 REMARK 465 ASP A 701 REMARK 465 TYR A 702 REMARK 465 TYR A 703 REMARK 465 ARG A 704 REMARK 465 GLN A 705 REMARK 465 GLY A 706 REMARK 465 ARG A 707 REMARK 465 ILE A 708 REMARK 465 ALA A 709 REMARK 465 LYS A 710 REMARK 465 MET A 711 REMARK 465 GLN A 814 REMARK 465 GLU A 815 REMARK 465 PRO A 816 REMARK 465 ASP A 817 REMARK 465 GLU A 818 REMARK 465 ASP B 558 REMARK 465 ASP B 559 REMARK 465 GLN B 606 REMARK 465 GLY B 607 REMARK 465 SER B 608 REMARK 465 GLU B 609 REMARK 465 GLN B 705 REMARK 465 GLY B 706 REMARK 465 ARG B 707 REMARK 465 PRO B 812 REMARK 465 ALA B 813 REMARK 465 GLN B 814 REMARK 465 GLU B 815 REMARK 465 PRO B 816 REMARK 465 ASP B 817 REMARK 465 GLU B 818 REMARK 465 GLY C 512 REMARK 465 SER C 513 REMARK 465 ASN C 514 REMARK 465 SER C 515 REMARK 465 LEU C 516 REMARK 465 GLY C 517 REMARK 465 ILE C 518 REMARK 465 SER C 519 REMARK 465 GLU C 520 REMARK 465 GLY C 607 REMARK 465 SER C 608 REMARK 465 GLU C 609 REMARK 465 ARG C 610 REMARK 465 GLU C 611 REMARK 465 SER C 612 REMARK 465 PHE C 613 REMARK 465 LYS C 696 REMARK 465 ILE C 697 REMARK 465 TYR C 698 REMARK 465 ASN C 699 REMARK 465 GLY C 700 REMARK 465 ASP C 701 REMARK 465 TYR C 702 REMARK 465 TYR C 703 REMARK 465 ARG C 704 REMARK 465 GLN C 705 REMARK 465 GLY C 706 REMARK 465 ARG C 707 REMARK 465 ILE C 708 REMARK 465 ALA C 709 REMARK 465 LYS C 710 REMARK 465 MET C 711 REMARK 465 GLN C 814 REMARK 465 GLU C 815 REMARK 465 PRO C 816 REMARK 465 ASP C 817 REMARK 465 GLU C 818 REMARK 465 ASP D 558 REMARK 465 ASP D 559 REMARK 465 GLN D 606 REMARK 465 GLY D 607 REMARK 465 SER D 608 REMARK 465 GLU D 609 REMARK 465 GLN D 705 REMARK 465 GLY D 706 REMARK 465 ARG D 707 REMARK 465 PRO D 812 REMARK 465 ALA D 813 REMARK 465 GLN D 814 REMARK 465 GLU D 815 REMARK 465 PRO D 816 REMARK 465 ASP D 817 REMARK 465 GLU D 818 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 557 45.59 -89.98 REMARK 500 ASP A 558 92.18 42.61 REMARK 500 ASP A 559 -28.52 102.37 REMARK 500 GLN A 640 79.84 -111.40 REMARK 500 ARG A 671 -12.42 75.27 REMARK 500 ASP A 672 49.34 -141.05 REMARK 500 ASP A 690 -59.44 74.10 REMARK 500 SER A 694 44.58 -88.19 REMARK 500 TYR A 750 72.74 49.74 REMARK 500 ASN B 514 -178.90 -175.81 REMARK 500 SER B 515 -9.70 -143.74 REMARK 500 ALA B 615 72.33 49.22 REMARK 500 ARG B 636 -34.10 -138.38 REMARK 500 ARG B 671 -10.58 73.06 REMARK 500 ASP B 690 86.45 61.22 REMARK 500 TYR B 698 -50.79 -130.27 REMARK 500 ASN B 699 -78.33 -86.24 REMARK 500 TYR B 750 70.90 47.26 REMARK 500 ASP C 558 86.57 10.44 REMARK 500 ASP C 559 -10.10 112.97 REMARK 500 ARG C 671 -12.45 74.88 REMARK 500 ASP C 672 49.36 -141.59 REMARK 500 ASP C 690 -59.43 75.83 REMARK 500 SER C 694 39.54 -80.06 REMARK 500 TYR C 750 72.31 49.40 REMARK 500 ASN D 514 -179.71 -179.14 REMARK 500 SER D 515 -9.48 -144.09 REMARK 500 ALA D 572 -71.86 -74.88 REMARK 500 ALA D 615 76.02 42.03 REMARK 500 ARG D 636 -33.54 -130.25 REMARK 500 ARG D 671 -9.79 72.53 REMARK 500 ASP D 690 83.62 60.61 REMARK 500 TYR D 698 -50.04 -130.60 REMARK 500 ASN D 699 -80.01 -86.55 REMARK 500 TYR D 750 70.96 47.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7YS A 9001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7YS B 9001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7YS C 9001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7YS D 9001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5U6C RELATED DB: PDB DBREF 5U6B A 514 818 UNP P30530 UFO_HUMAN 514 818 DBREF 5U6B B 514 818 UNP P30530 UFO_HUMAN 514 818 DBREF 5U6B C 514 818 UNP P30530 UFO_HUMAN 514 818 DBREF 5U6B D 514 818 UNP P30530 UFO_HUMAN 514 818 SEQADV 5U6B GLY A 512 UNP P30530 EXPRESSION TAG SEQADV 5U6B SER A 513 UNP P30530 EXPRESSION TAG SEQADV 5U6B GLY B 512 UNP P30530 EXPRESSION TAG SEQADV 5U6B SER B 513 UNP P30530 EXPRESSION TAG SEQADV 5U6B GLY C 512 UNP P30530 EXPRESSION TAG SEQADV 5U6B SER C 513 UNP P30530 EXPRESSION TAG SEQADV 5U6B GLY D 512 UNP P30530 EXPRESSION TAG SEQADV 5U6B SER D 513 UNP P30530 EXPRESSION TAG SEQRES 1 A 307 GLY SER ASN SER LEU GLY ILE SER GLU GLU LEU LYS GLU SEQRES 2 A 307 LYS LEU ARG ASP VAL MET VAL ASP ARG HIS LYS VAL ALA SEQRES 3 A 307 LEU GLY LYS THR LEU GLY GLU GLY GLU PHE GLY ALA VAL SEQRES 4 A 307 MET GLU GLY GLN LEU ASN GLN ASP ASP SER ILE LEU LYS SEQRES 5 A 307 VAL ALA VAL LYS THR MET LYS ILE ALA ILE CYS THR ARG SEQRES 6 A 307 SER GLU LEU GLU ASP PHE LEU SER GLU ALA VAL CYS MET SEQRES 7 A 307 LYS GLU PHE ASP HIS PRO ASN VAL MET ARG LEU ILE GLY SEQRES 8 A 307 VAL CYS PHE GLN GLY SER GLU ARG GLU SER PHE PRO ALA SEQRES 9 A 307 PRO VAL VAL ILE LEU PRO PHE MET LYS HIS GLY ASP LEU SEQRES 10 A 307 HIS SER PHE LEU LEU TYR SER ARG LEU GLY ASP GLN PRO SEQRES 11 A 307 VAL TYR LEU PRO THR GLN MET LEU VAL LYS PHE MET ALA SEQRES 12 A 307 ASP ILE ALA SER GLY MET GLU TYR LEU SER THR LYS ARG SEQRES 13 A 307 PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS MET LEU SEQRES 14 A 307 ASN GLU ASN MET SER VAL CYS VAL ALA ASP PHE GLY LEU SEQRES 15 A 307 SER LYS LYS ILE TYR ASN GLY ASP TYR TYR ARG GLN GLY SEQRES 16 A 307 ARG ILE ALA LYS MET PRO VAL LYS TRP ILE ALA ILE GLU SEQRES 17 A 307 SER LEU ALA ASP ARG VAL TYR THR SER LYS SER ASP VAL SEQRES 18 A 307 TRP SER PHE GLY VAL THR MET TRP GLU ILE ALA THR ARG SEQRES 19 A 307 GLY GLN THR PRO TYR PRO GLY VAL GLU ASN SER GLU ILE SEQRES 20 A 307 TYR ASP TYR LEU ARG GLN GLY ASN ARG LEU LYS GLN PRO SEQRES 21 A 307 ALA ASP CYS LEU ASP GLY LEU TYR ALA LEU MET SER ARG SEQRES 22 A 307 CYS TRP GLU LEU ASN PRO GLN ASP ARG PRO SER PHE THR SEQRES 23 A 307 GLU LEU ARG GLU ASP LEU GLU ASN THR LEU LYS ALA LEU SEQRES 24 A 307 PRO PRO ALA GLN GLU PRO ASP GLU SEQRES 1 B 307 GLY SER ASN SER LEU GLY ILE SER GLU GLU LEU LYS GLU SEQRES 2 B 307 LYS LEU ARG ASP VAL MET VAL ASP ARG HIS LYS VAL ALA SEQRES 3 B 307 LEU GLY LYS THR LEU GLY GLU GLY GLU PHE GLY ALA VAL SEQRES 4 B 307 MET GLU GLY GLN LEU ASN GLN ASP ASP SER ILE LEU LYS SEQRES 5 B 307 VAL ALA VAL LYS THR MET LYS ILE ALA ILE CYS THR ARG SEQRES 6 B 307 SER GLU LEU GLU ASP PHE LEU SER GLU ALA VAL CYS MET SEQRES 7 B 307 LYS GLU PHE ASP HIS PRO ASN VAL MET ARG LEU ILE GLY SEQRES 8 B 307 VAL CYS PHE GLN GLY SER GLU ARG GLU SER PHE PRO ALA SEQRES 9 B 307 PRO VAL VAL ILE LEU PRO PHE MET LYS HIS GLY ASP LEU SEQRES 10 B 307 HIS SER PHE LEU LEU TYR SER ARG LEU GLY ASP GLN PRO SEQRES 11 B 307 VAL TYR LEU PRO THR GLN MET LEU VAL LYS PHE MET ALA SEQRES 12 B 307 ASP ILE ALA SER GLY MET GLU TYR LEU SER THR LYS ARG SEQRES 13 B 307 PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS MET LEU SEQRES 14 B 307 ASN GLU ASN MET SER VAL CYS VAL ALA ASP PHE GLY LEU SEQRES 15 B 307 SER LYS LYS ILE TYR ASN GLY ASP TYR TYR ARG GLN GLY SEQRES 16 B 307 ARG ILE ALA LYS MET PRO VAL LYS TRP ILE ALA ILE GLU SEQRES 17 B 307 SER LEU ALA ASP ARG VAL TYR THR SER LYS SER ASP VAL SEQRES 18 B 307 TRP SER PHE GLY VAL THR MET TRP GLU ILE ALA THR ARG SEQRES 19 B 307 GLY GLN THR PRO TYR PRO GLY VAL GLU ASN SER GLU ILE SEQRES 20 B 307 TYR ASP TYR LEU ARG GLN GLY ASN ARG LEU LYS GLN PRO SEQRES 21 B 307 ALA ASP CYS LEU ASP GLY LEU TYR ALA LEU MET SER ARG SEQRES 22 B 307 CYS TRP GLU LEU ASN PRO GLN ASP ARG PRO SER PHE THR SEQRES 23 B 307 GLU LEU ARG GLU ASP LEU GLU ASN THR LEU LYS ALA LEU SEQRES 24 B 307 PRO PRO ALA GLN GLU PRO ASP GLU SEQRES 1 C 307 GLY SER ASN SER LEU GLY ILE SER GLU GLU LEU LYS GLU SEQRES 2 C 307 LYS LEU ARG ASP VAL MET VAL ASP ARG HIS LYS VAL ALA SEQRES 3 C 307 LEU GLY LYS THR LEU GLY GLU GLY GLU PHE GLY ALA VAL SEQRES 4 C 307 MET GLU GLY GLN LEU ASN GLN ASP ASP SER ILE LEU LYS SEQRES 5 C 307 VAL ALA VAL LYS THR MET LYS ILE ALA ILE CYS THR ARG SEQRES 6 C 307 SER GLU LEU GLU ASP PHE LEU SER GLU ALA VAL CYS MET SEQRES 7 C 307 LYS GLU PHE ASP HIS PRO ASN VAL MET ARG LEU ILE GLY SEQRES 8 C 307 VAL CYS PHE GLN GLY SER GLU ARG GLU SER PHE PRO ALA SEQRES 9 C 307 PRO VAL VAL ILE LEU PRO PHE MET LYS HIS GLY ASP LEU SEQRES 10 C 307 HIS SER PHE LEU LEU TYR SER ARG LEU GLY ASP GLN PRO SEQRES 11 C 307 VAL TYR LEU PRO THR GLN MET LEU VAL LYS PHE MET ALA SEQRES 12 C 307 ASP ILE ALA SER GLY MET GLU TYR LEU SER THR LYS ARG SEQRES 13 C 307 PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS MET LEU SEQRES 14 C 307 ASN GLU ASN MET SER VAL CYS VAL ALA ASP PHE GLY LEU SEQRES 15 C 307 SER LYS LYS ILE TYR ASN GLY ASP TYR TYR ARG GLN GLY SEQRES 16 C 307 ARG ILE ALA LYS MET PRO VAL LYS TRP ILE ALA ILE GLU SEQRES 17 C 307 SER LEU ALA ASP ARG VAL TYR THR SER LYS SER ASP VAL SEQRES 18 C 307 TRP SER PHE GLY VAL THR MET TRP GLU ILE ALA THR ARG SEQRES 19 C 307 GLY GLN THR PRO TYR PRO GLY VAL GLU ASN SER GLU ILE SEQRES 20 C 307 TYR ASP TYR LEU ARG GLN GLY ASN ARG LEU LYS GLN PRO SEQRES 21 C 307 ALA ASP CYS LEU ASP GLY LEU TYR ALA LEU MET SER ARG SEQRES 22 C 307 CYS TRP GLU LEU ASN PRO GLN ASP ARG PRO SER PHE THR SEQRES 23 C 307 GLU LEU ARG GLU ASP LEU GLU ASN THR LEU LYS ALA LEU SEQRES 24 C 307 PRO PRO ALA GLN GLU PRO ASP GLU SEQRES 1 D 307 GLY SER ASN SER LEU GLY ILE SER GLU GLU LEU LYS GLU SEQRES 2 D 307 LYS LEU ARG ASP VAL MET VAL ASP ARG HIS LYS VAL ALA SEQRES 3 D 307 LEU GLY LYS THR LEU GLY GLU GLY GLU PHE GLY ALA VAL SEQRES 4 D 307 MET GLU GLY GLN LEU ASN GLN ASP ASP SER ILE LEU LYS SEQRES 5 D 307 VAL ALA VAL LYS THR MET LYS ILE ALA ILE CYS THR ARG SEQRES 6 D 307 SER GLU LEU GLU ASP PHE LEU SER GLU ALA VAL CYS MET SEQRES 7 D 307 LYS GLU PHE ASP HIS PRO ASN VAL MET ARG LEU ILE GLY SEQRES 8 D 307 VAL CYS PHE GLN GLY SER GLU ARG GLU SER PHE PRO ALA SEQRES 9 D 307 PRO VAL VAL ILE LEU PRO PHE MET LYS HIS GLY ASP LEU SEQRES 10 D 307 HIS SER PHE LEU LEU TYR SER ARG LEU GLY ASP GLN PRO SEQRES 11 D 307 VAL TYR LEU PRO THR GLN MET LEU VAL LYS PHE MET ALA SEQRES 12 D 307 ASP ILE ALA SER GLY MET GLU TYR LEU SER THR LYS ARG SEQRES 13 D 307 PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS MET LEU SEQRES 14 D 307 ASN GLU ASN MET SER VAL CYS VAL ALA ASP PHE GLY LEU SEQRES 15 D 307 SER LYS LYS ILE TYR ASN GLY ASP TYR TYR ARG GLN GLY SEQRES 16 D 307 ARG ILE ALA LYS MET PRO VAL LYS TRP ILE ALA ILE GLU SEQRES 17 D 307 SER LEU ALA ASP ARG VAL TYR THR SER LYS SER ASP VAL SEQRES 18 D 307 TRP SER PHE GLY VAL THR MET TRP GLU ILE ALA THR ARG SEQRES 19 D 307 GLY GLN THR PRO TYR PRO GLY VAL GLU ASN SER GLU ILE SEQRES 20 D 307 TYR ASP TYR LEU ARG GLN GLY ASN ARG LEU LYS GLN PRO SEQRES 21 D 307 ALA ASP CYS LEU ASP GLY LEU TYR ALA LEU MET SER ARG SEQRES 22 D 307 CYS TRP GLU LEU ASN PRO GLN ASP ARG PRO SER PHE THR SEQRES 23 D 307 GLU LEU ARG GLU ASP LEU GLU ASN THR LEU LYS ALA LEU SEQRES 24 D 307 PRO PRO ALA GLN GLU PRO ASP GLU HET 7YS A9001 32 HET 7YS B9001 32 HET 7YS C9001 32 HET 7YS D9001 32 HETNAM 7YS (10R)-7-AMINO-11-CHLORO-12-FLUORO-1-(2-HYDROXYETHYL)-3, HETNAM 2 7YS 10,16-TRIMETHYL-16,17-DIHYDRO-1H-8,4-(AZENO) HETNAM 3 7YS PYRAZOLO[4,3-H][2,5,11]BENZOXADIAZACYCLOTETRADECIN- HETNAM 4 7YS 15(10H)-ONE FORMUL 5 7YS 4(C21 H22 CL F N6 O3) HELIX 1 AA1 LYS A 523 MET A 530 1 8 HELIX 2 AA2 ASP A 532 HIS A 534 5 3 HELIX 3 AA3 THR A 575 GLU A 591 1 17 HELIX 4 AA4 ASP A 627 GLY A 638 1 12 HELIX 5 AA5 PRO A 645 LYS A 666 1 22 HELIX 6 AA6 ALA A 674 ARG A 676 5 3 HELIX 7 AA7 PRO A 712 ILE A 716 5 5 HELIX 8 AA8 ALA A 717 ARG A 724 1 8 HELIX 9 AA9 THR A 727 THR A 744 1 18 HELIX 10 AB1 GLU A 754 GLN A 764 1 11 HELIX 11 AB2 LEU A 775 TRP A 786 1 12 HELIX 12 AB3 ASN A 789 ARG A 793 5 5 HELIX 13 AB4 SER A 795 LEU A 810 1 16 HELIX 14 AB5 SER B 519 ARG B 527 1 9 HELIX 15 AB6 ASP B 532 HIS B 534 5 3 HELIX 16 AB7 THR B 575 LEU B 583 1 9 HELIX 17 AB8 LEU B 583 LYS B 590 1 8 HELIX 18 AB9 ASP B 627 TYR B 634 1 8 HELIX 19 AC1 PRO B 645 LYS B 666 1 22 HELIX 20 AC2 ALA B 674 ARG B 676 5 3 HELIX 21 AC3 ALA B 717 ARG B 724 1 8 HELIX 22 AC4 THR B 727 ARG B 745 1 19 HELIX 23 AC5 GLU B 754 GLN B 764 1 11 HELIX 24 AC6 LEU B 775 TRP B 786 1 12 HELIX 25 AC7 ASN B 789 ARG B 793 5 5 HELIX 26 AC8 SER B 795 LEU B 810 1 16 HELIX 27 AC9 LYS C 523 MET C 530 1 8 HELIX 28 AD1 ASP C 532 HIS C 534 5 3 HELIX 29 AD2 THR C 575 GLU C 591 1 17 HELIX 30 AD3 ASP C 627 GLY C 638 1 12 HELIX 31 AD4 PRO C 645 LYS C 666 1 22 HELIX 32 AD5 ALA C 674 ARG C 676 5 3 HELIX 33 AD6 PRO C 712 ILE C 716 5 5 HELIX 34 AD7 ALA C 717 ARG C 724 1 8 HELIX 35 AD8 THR C 727 THR C 744 1 18 HELIX 36 AD9 GLU C 754 GLN C 764 1 11 HELIX 37 AE1 LEU C 775 TRP C 786 1 12 HELIX 38 AE2 ASN C 789 ARG C 793 5 5 HELIX 39 AE3 SER C 795 LEU C 810 1 16 HELIX 40 AE4 SER D 519 LEU D 526 1 8 HELIX 41 AE5 ASP D 532 HIS D 534 5 3 HELIX 42 AE6 THR D 575 LEU D 583 1 9 HELIX 43 AE7 LEU D 583 LYS D 590 1 8 HELIX 44 AE8 ASP D 627 TYR D 634 1 8 HELIX 45 AE9 PRO D 645 LYS D 666 1 22 HELIX 46 AF1 ALA D 674 ARG D 676 5 3 HELIX 47 AF2 ALA D 717 ARG D 724 1 8 HELIX 48 AF3 THR D 727 THR D 744 1 18 HELIX 49 AF4 GLU D 754 GLN D 764 1 11 HELIX 50 AF5 LEU D 775 TRP D 786 1 12 HELIX 51 AF6 ASN D 789 ARG D 793 5 5 HELIX 52 AF7 SER D 795 LEU D 810 1 16 SHEET 1 AA1 5 VAL A 536 GLU A 544 0 SHEET 2 AA1 5 GLY A 548 ASN A 556 -1 O GLU A 552 N LYS A 540 SHEET 3 AA1 5 ILE A 561 MET A 569 -1 O LEU A 562 N LEU A 555 SHEET 4 AA1 5 PRO A 616 PRO A 621 -1 O PRO A 616 N MET A 569 SHEET 5 AA1 5 GLY A 602 PHE A 605 -1 N GLY A 602 O ILE A 619 SHEET 1 AA2 2 CYS A 678 LEU A 680 0 SHEET 2 AA2 2 VAL A 686 VAL A 688 -1 O CYS A 687 N MET A 679 SHEET 1 AA3 6 MET B 530 VAL B 531 0 SHEET 2 AA3 6 GLY B 602 CYS B 604 1 O VAL B 603 N VAL B 531 SHEET 3 AA3 6 VAL B 617 PRO B 621 -1 O ILE B 619 N GLY B 602 SHEET 4 AA3 6 LEU B 562 LYS B 567 -1 N ALA B 565 O LEU B 620 SHEET 5 AA3 6 ALA B 549 LEU B 555 -1 N MET B 551 O VAL B 566 SHEET 6 AA3 6 VAL B 536 GLU B 544 -1 N LYS B 540 O GLU B 552 SHEET 1 AA4 2 PHE B 668 ILE B 669 0 SHEET 2 AA4 2 LYS B 695 LYS B 696 -1 O LYS B 695 N ILE B 669 SHEET 1 AA5 2 CYS B 678 LEU B 680 0 SHEET 2 AA5 2 VAL B 686 VAL B 688 -1 O CYS B 687 N MET B 679 SHEET 1 AA6 5 VAL C 536 GLU C 544 0 SHEET 2 AA6 5 GLY C 548 GLN C 557 -1 O GLU C 552 N LYS C 540 SHEET 3 AA6 5 SER C 560 MET C 569 -1 O VAL C 566 N MET C 551 SHEET 4 AA6 5 PRO C 616 PRO C 621 -1 O VAL C 618 N LYS C 567 SHEET 5 AA6 5 GLY C 602 PHE C 605 -1 N GLY C 602 O ILE C 619 SHEET 1 AA7 2 CYS C 678 LEU C 680 0 SHEET 2 AA7 2 VAL C 686 VAL C 688 -1 O CYS C 687 N MET C 679 SHEET 1 AA8 6 MET D 530 VAL D 531 0 SHEET 2 AA8 6 GLY D 602 CYS D 604 1 O VAL D 603 N VAL D 531 SHEET 3 AA8 6 VAL D 617 PRO D 621 -1 O ILE D 619 N GLY D 602 SHEET 4 AA8 6 LEU D 562 LYS D 567 -1 N ALA D 565 O LEU D 620 SHEET 5 AA8 6 ALA D 549 LEU D 555 -1 N MET D 551 O VAL D 566 SHEET 6 AA8 6 VAL D 536 GLU D 544 -1 N LYS D 540 O GLU D 552 SHEET 1 AA9 2 PHE D 668 ILE D 669 0 SHEET 2 AA9 2 LYS D 695 LYS D 696 -1 O LYS D 695 N ILE D 669 SHEET 1 AB1 2 CYS D 678 LEU D 680 0 SHEET 2 AB1 2 VAL D 686 VAL D 688 -1 O CYS D 687 N MET D 679 CISPEP 1 PRO A 812 ALA A 813 0 -0.21 CISPEP 2 GLY B 512 SER B 513 0 0.58 CISPEP 3 SER B 513 ASN B 514 0 -3.54 CISPEP 4 PRO C 812 ALA C 813 0 0.23 CISPEP 5 GLY D 512 SER D 513 0 2.46 CISPEP 6 SER D 513 ASN D 514 0 -5.56 SITE 1 AC1 14 LEU A 542 VAL A 550 ALA A 565 MET A 598 SITE 2 AC1 14 LEU A 620 PRO A 621 PHE A 622 MET A 623 SITE 3 AC1 14 GLY A 626 ASP A 627 ARG A 676 ASN A 677 SITE 4 AC1 14 MET A 679 ALA A 689 SITE 1 AC2 13 VAL B 550 ALA B 565 LYS B 567 MET B 598 SITE 2 AC2 13 PRO B 621 PHE B 622 MET B 623 GLY B 626 SITE 3 AC2 13 ASP B 627 ARG B 676 ASN B 677 MET B 679 SITE 4 AC2 13 ALA B 689 SITE 1 AC3 14 LEU C 542 GLY C 543 VAL C 550 ALA C 565 SITE 2 AC3 14 MET C 598 PRO C 621 PHE C 622 MET C 623 SITE 3 AC3 14 GLY C 626 ASP C 627 ARG C 676 ASN C 677 SITE 4 AC3 14 MET C 679 ALA C 689 SITE 1 AC4 13 VAL D 550 ALA D 565 LYS D 567 MET D 598 SITE 2 AC4 13 PRO D 621 PHE D 622 MET D 623 GLY D 626 SITE 3 AC4 13 ASP D 627 ARG D 676 ASN D 677 MET D 679 SITE 4 AC4 13 ALA D 689 CRYST1 81.680 100.704 81.921 90.00 93.97 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012243 0.000000 0.000850 0.00000 SCALE2 0.000000 0.009930 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012236 0.00000